Molecular Partners AG at JPMorgan Healthcare Conference Transcript
Welcome to the Molecular Partners Presentation at the 41st JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst with JPMorgan, and it's my great pleasure to introduce Patrick Amstutz, the CEO of Molecular Partners. Before I hand over to Patrick, I'd just remind everyone that we will stay in this room for Q&A. And if you just put up your hand and wait for a microphone, and then we'll address your question. Patrick, great to see you.
Thanks, Richard, for the kind intro. My name is Patrick Amstutz, I'm the CEO of Molecular Partners, and a warm welcome to -- from my side to those in the room and also those on the webcast. It's really great to be here and a special thanks to JPMorgan for organizing and making this an in-person meeting. It's been great to be on the street, meet people and truly energizing an important moment, I think, for the industry. So special
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
